Marshall Wace, LLP Olink Holding Ab (Publ) Transaction History

Marshall Wace, LLP

  • $77.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$21.87 - $25.59 $164,462 - $192,436
7,520 Added 1.36%
558,569 $14.2 Million
Q1 2024

May 15, 2024
BUY
$21.81 - $25.14 $10.3 Million - $11.8 Million
470,049 Added 580.31%
551,049 $13 Million
Q4 2023

Feb 14, 2024
BUY
$14.29 - $25.95 $1.16 Million - $2.1 Million
81,000 New
81,000 $2.04 Million
Q4 2021

Feb 14, 2022
SELL
$18.0 - $34.82 $212,598 - $411,259
-11,811 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$23.42 - $37.93 $276,613 - $447,991
11,811 New
11,811 $287,000

Others Institutions Holding OLK

# of Institutions
52
Shares Held
15.9M
Call Options Held
34.9K
Put Options Held
110K
View Full List

About Olink Holding AB (publ)

OLK Quotes by TradingView
  • Ticker OLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 119,098,000
  • Description
  • Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...
More about OLK
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email